143 related articles for article (PubMed ID: 22264301)
1. Concurrent hypermethylation of DNMT1, MGMT and EGFR genes in progression of gliomas.
Gömöri E; Pál J; Kovács B; Dóczi T
Diagn Pathol; 2012 Jan; 7():8. PubMed ID: 22264301
[TBL] [Abstract][Full Text] [Related]
2. Incidence of biomarkers in high-grade gliomas and their impact on survival in a diverse SouthEast Asian cohort - a population-based study.
Ang SYL; Lee L; See AAQ; Ang TY; Ang BT; King NKK
BMC Cancer; 2020 Jan; 20(1):79. PubMed ID: 32005184
[TBL] [Abstract][Full Text] [Related]
3. Total DNA methylation profile in assessing the MGMT gene promoter status in malignant gliomas.
Petrova EI; Galstyan SA; Telysheva EN; Ryzhova MV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):52-58. PubMed ID: 38054227
[TBL] [Abstract][Full Text] [Related]
4. MRI-Based Deep-Learning Method for Determining Glioma
Yogananda CGB; Shah BR; Nalawade SS; Murugesan GK; Yu FF; Pinho MC; Wagner BC; Mickey B; Patel TR; Fei B; Madhuranthakam AJ; Maldjian JA
AJNR Am J Neuroradiol; 2021 May; 42(5):845-852. PubMed ID: 33664111
[TBL] [Abstract][Full Text] [Related]
5.
Kong Z; Lin Y; Jiang C; Li L; Liu Z; Wang Y; Dai C; Liu D; Qin X; Wang Y; Liu Z; Cheng X; Tian J; Ma W
Cancer Imaging; 2019 Aug; 19(1):58. PubMed ID: 31426864
[TBL] [Abstract][Full Text] [Related]
6. Exploring MGMT methylation-driven structural connectivity changes in insular gliomas: a tractography and graph theoretical analysis.
Yang ZC; Yin CD; Yeh FC; Xue BW; Song XY; Li G; Sun SJ; Deng ZH; Hou ZG; Xie J
J Neurooncol; 2024 Jan; 166(1):155-165. PubMed ID: 38150062
[TBL] [Abstract][Full Text] [Related]
7. Ten genes associated with MGMT promoter methylation predict the prognosis of patients with glioma.
Zhang Y; Zhu J
Oncol Rep; 2019 Feb; 41(2):908-916. PubMed ID: 30535433
[TBL] [Abstract][Full Text] [Related]
8. MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas.
Zhao B; Qi H; Ma W
JAMA Oncol; 2023 Dec; 9(12):1734-1735. PubMed ID: 37856142
[No Abstract] [Full Text] [Related]
9. The Role of
Skiriute D; Stakaitis R; Steponaitis G; Tamasauskas A; Vaitkiene P
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33120918
[TBL] [Abstract][Full Text] [Related]
10. MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas-Reply.
Kinslow CJ; Cheng SK; Wang TJC
JAMA Oncol; 2023 Dec; 9(12):1735-1736. PubMed ID: 37856114
[No Abstract] [Full Text] [Related]
11. Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.
Jonsson P; Lin AL; Young RJ; DiStefano NM; Hyman DM; Li BT; Berger MF; Zehir A; Ladanyi M; Solit DB; Arnold AG; Stadler ZK; Mandelker D; Goldberg ME; Chmielecki J; Pourmaleki M; Ogilvie SQ; Chavan SS; McKeown AT; Manne M; Hyde A; Beal K; Yang TJ; Nolan CP; Pentsova E; Omuro A; Gavrilovic IT; Kaley TJ; Diamond EL; Stone JB; Grommes C; Boire A; Daras M; Piotrowski AF; Miller AM; Gutin PH; Chan TA; Tabar VS; Brennan CW; Rosenblum M; DeAngelis LM; Mellinghoff IK; Taylor BS
Clin Cancer Res; 2019 Sep; 25(18):5537-5547. PubMed ID: 31263031
[TBL] [Abstract][Full Text] [Related]
12. The next generation of glioma biomarkers: MGMT methylation, BRAF fusions and IDH1 mutations.
von Deimling A; Korshunov A; Hartmann C
Brain Pathol; 2011 Jan; 21(1):74-87. PubMed ID: 21129061
[TBL] [Abstract][Full Text] [Related]
13. Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas.
Liu BL; Cheng JX; Zhang W; Zhang X; Wang R; Lin H; Huo JL; Cheng H
Neuro Oncol; 2010 Jun; 12(6):540-8. PubMed ID: 20154338
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of promoter hypermethylation in RASSF1A and MGMT in retinoblastoma.
Choy KW; Lee TC; Cheung KF; Fan DS; Lo KW; Beaverson KL; Abramson DH; Lam DS; Yu CB; Pang CP
Neoplasia; 2005 Mar; 7(3):200-6. PubMed ID: 15799820
[TBL] [Abstract][Full Text] [Related]
15. MGMT promoter hypermethylation and K-RAS, PTEN and TP53 mutations in tamoxifen-exposed and non-exposed endometrial cancer cases.
Nagy E; Gajjar KB; Patel II; Taylor S; Martin-Hirsch PL; Stringfellow HF; Martin FL; Phillips DH
Br J Cancer; 2014 Jun; 110(12):2874-80. PubMed ID: 24853176
[TBL] [Abstract][Full Text] [Related]
16. Molecular epigenetics and genetics in neuro-oncology.
Nagarajan RP; Costello JF
Neurotherapeutics; 2009 Jul; 6(3):436-46. PubMed ID: 19560734
[TBL] [Abstract][Full Text] [Related]
17. Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas.
Nakashima T; Yamamoto R; Ohno M; Sugino H; Takahashi M; Funakoshi Y; Nambu S; Uneda A; Yanagisawa S; Uzuka T; Arakawa Y; Hanaya R; Ishida J; Yoshimoto K; Saito R; Narita Y; Suzuki H
Brain Tumor Pathol; 2024 Apr; 41(2):50-60. PubMed ID: 38332448
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of O6-methylguanine-DNA methyltransferase in human lung adenocarcinoma relates to high-grade histology and worse prognosis among smokers.
Hayashi H; Yazawa T; Okudela K; Nagai J; Ito T; Kanisawa M; Kitamura H
Jpn J Cancer Res; 2002 Feb; 93(2):184-9. PubMed ID: 11856482
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation analysis with methylation-sensitive high-resolution melting (MS-HRM) reveals gene panel for glioma characteristics.
Majchrzak-Celińska A; Dybska E; Barciszewska AM
CNS Neurosci Ther; 2020 Dec; 26(12):1303-1314. PubMed ID: 32783304
[TBL] [Abstract][Full Text] [Related]
20. STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes.
Zhang Q; Wang HY; Marzec M; Raghunath PN; Nagasawa T; Wasik MA
Proc Natl Acad Sci U S A; 2005 May; 102(19):6948-53. PubMed ID: 15870198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
